Presenting patients with a choice of screening options didn't result in more patients getting screened for colorectal cancer, according to a study published in JAMA Network Open.
Researchers examined how offering patients fecal immunochemical testing as an alternative to colonoscopy affected CRC screening rates. Researchers assigned 483 study participants to one of three cohorts, each of which received one of the following:
1. An option to schedule a colonoscopy
2. An option to schedule a colonoscopy or receive a FIT kit if they didn't respond in four weeks
3. An option to schedule a colonoscopy and receive a FIT kit simultaneously
Researchers measured whether patients completed the CRC screening test within four months of initial outreach. Completion rates were, per respective group: 14.4 percent, 17.1 percent and 19.9 percent. Completion rates were not statistically more significant than those in the colonoscopy-only group.
Concerning patients who completed a screening, 90.5 percent chose to get a colonoscopy in the colonoscopy-only group. In the other groups, 52 percent chose colonoscopy over the delayed FIT and 37.9 percent chose colonoscopy when presented with both options simultaneously.
Read the entire study abstract here.
More articles on surgery centers:
ASC supply chain tip of the day: Use an inventory module
3 ways to ensure smooth adoption of new ASC technology
NTT Data, Tenet partner to deliver technology services